Comparison of Two Drugs Regimen in Treatment of Complicated Typhoid Fever in Children

NCT04154722 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2021-06-16

No results posted yet for this study

Summary

This study evaluates whether XDR Typhoid fever in children can be effectively treated with monotherapy (meropenum alone), or a combination (meropenum and azithromycin).

Conditions

  • Typhoid Fever

Interventions

DRUG

Meropenem Injection

inj meropenum for 10 days

DRUG

Azithromycin Powder

syp azithromycin for10days

Sponsors & Collaborators

  • Ziauddin University

    lead OTHER

Principal Investigators

  • farhana zafar, mbbs,fcps · ziauddin university north campus

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-20
Primary Completion
2020-12-30
Completion
2020-12-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04154722 on ClinicalTrials.gov